Cyclodextrin-based pharmaceutics: past, present and future.
Cyclodextrins are cyclic oligomers of glucose that can form water-soluble inclusion complexes with small molecules and portions of large compounds. These biocompatible, cyclic oligosaccharides do not elicit immune responses and have low toxicities in animals and humans. Cyclodextrins are used in pharmaceutical applications for numerous purposes, including improving the bioavailability of drugs. Current cyclodextrin-based therapeutics are described and possible future applications discussed. Cyclodextrin-containing polymers are reviewed and their use in drug delivery presented. Of specific interest is the use of cyclodextrin-containing polymers to provide unique capabilities for the delivery of nucleic acids.
Davis
Mark E
ME
Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA. mdavis@cheme.caltech.edu
Brewster
Marcus E
ME
D000818:Animals; D001702:Biopharmaceutics / Q000379:methods* / Q000639:trends*; D003505:Cyclodextrins / Q000008:administration & dosage / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends; D005079:Excipients / Q000008:administration & dosage / Q000737:chemistry; D005544:Forecasting; D006801:Humans
D003505:Cyclodextrins; D005079:Excipients